A securities fraud suit against GPGI, the former CompoSecure, covers stock purchases from Nov 3, 2025 through May 6, 2026. Investors seeking to steer the litigation must act by Sept 14, 2026.
A securities fraud suit against GPGI, the former CompoSecure, covers stock purchases from Nov 3, 2025 through May 6, 2026. Investors seeking to steer the litigation must act by Sept 14, 2026.

A Sept 14 deadline looms for GPGI investors seeking to lead a securities class action tied to the company's Husky Technologies acquisition.
Kaplan Fox & Kilsheimer brought the complaint on behalf of shareholders who acquired GPGI Class A common stock between Nov 3, 2025 and May 6, 2026, the firm said in a Sept 2 notice. The suit alleges GPGI, formerly CompoSecure, overstated the value of Husky Technologies and misrepresented the deal's benefits to win shareholder approval and secure financing while enriching management.
Rosen Law Firm has filed a parallel action with similar claims, according to published notices. Both firms contend defendants used the Husky transaction to obtain funding and enrich executives while harming investors who bought shares during the class period. The class period dates vary slightly across the different filings, reflecting differences in when the deal closed and when alleged disclosures occurred.
GPGI trades on the NYSE under ticker GPGI, having previously operated as CompoSecure under ticker CMPO. The company completed its acquisition of Husky Technologies during the class period, according to the filings.
Investors seeking lead plaintiff status must file motions by Sept 14, 2026. The lead plaintiff directs the litigation and can influence settlement terms. Shareholders who do not seek lead plaintiff status may still be eligible to participate in any recovery as class members.
Kaplan Fox said investors with significant losses should contact the firm before the deadline. The firm noted that representation is available on a contingency basis, meaning no upfront costs for eligible shareholders. Both firms emphasized their track records in securities litigation in their respective notices.
The Sept 14 deadline creates a concentrated window for investor action. Additional plaintiffs joining the case could increase legal pressure on GPGI and potentially expand the scope of damages sought. The company faces potential financial liabilities, management distraction, and reputational damage as the litigation progresses. Investors will watch for the court's appointment of lead counsel and any subsequent motions to dismiss from GPGI, which could shape the case's trajectory into 2027.
This article is for informational purposes only and does not constitute investment advice.